Searched for: department:Medicine. General Internal Medicine
recentyears:2
school:SOM
Timely administration of proton pump inhibitors in an urban community hospital setting: A quality improvement project [Meeting Abstract]
Shahnazarian, V; Aamar, A; Kolli, S; Nagaraj, S; Ramai, D; Reddy, M
INTRODUCTION: Timing of certain proton pump inhibitors (PPIs) administration plays an important role in their efficacy. Delayed release capsules of omeprazole and lansoprazole should be taken 30 minutes before breakfast. Studies have demonstrated increased efficacy of PPIs when administered 30-60 minutes before breakfast.
METHOD(S): We performed a retrospective chart review of the patients admitted in the hospital in December 2018. All adult patients in the hospital who were on any PPI were included. Patients on twice daily PPI dosing were excluded. Data was collected on timing of PPI administration. An EHR intervention was implemented where the default frequency for PPI administration was changed from ?daily? to ?before breakfast? which meant it would be given at least 30 minutes before breakfast. After the intervention, chart review was done to collect the data for patients admitted in March 2019.
RESULT(S): Out of 100 patients reviewed before the intervention, none received PPI 30 minutes before breakfast due to EHR order of ?daily? dosing which meant PPI was administration at 10 AM. After the EHR intervention, data of 100 patients on PPI was reviewed. All patients received PPI 30 minutes before the breakfast. This was a 100% improvement from pre-intervention.
CONCLUSION(S): PPIs were not being administered at the optimal time before the intervention. While only some PPIs must be administered 30 minutes before meals, it was decided that all will be administered this way as to simplify discharge instruction for patients (not knowing exactly which PPI the primary team would be discharging them with). A simple EHR intervention was implemented that resulted in 100% compliance with appropriate timing of PPI administration
EMBASE:633655190
ISSN: 1572-0241
CID: 4720682
Robotic-Assisted Endoscopic Submucosal Dissection of Distal Colon and Rectal Lesions [Meeting Abstract]
Cui, Y; Hartz, K M; Bernstein, M; Obias, V; Mathew, A; Bardakcioglu, O; Horner, L; Shah, P; Kim, S; Haber, G; Gross, S A
INTRODUCTION: Endoscopic submucosal dissection (ESD) and endoscopic full-thickness resection (EFTR) are therapeutic alternatives to surgery for resection of colon and rectal lesions. In regards to large colon and rectal polyps and tumors, both ESD and EFTR have high en bloc resection rates and low recurrence rates, but are limited by training, procedure length, stability, and instrumentation. The Robotic System (RS) is a new robot-assisted endoscopic platform with multiple degrees of freedom allowing improved visualization, dexterity, and tissue manipulation with traction. This is the first U.S. experience assessing the feasibility and safety of robot-assisted ESD and EFTR in resection of distal colon and rectal lesions and its implication for polyps and tumors.
METHOD(S): This is a multicenter retrospective study from five institutions. Patients with distal colon or rectal lesions who underwent either ESD or EFTR with the RS were included. Each patient's clinical history, endoscopic findings, procedural records, and pathology records were reviewed.
RESULT(S): Forty-one patients underwent either ESD or EFTR with the RS for distal colon or rectal lesions, with an average total resection time of 135.0 minutes (s 62.8, n = 24). On average, lesions were 9.3 cm from the anal verge (range: 2 cm to 17 cm, n = 35) and were 30.0 mm in max diameter (range: 9 to 77 mm, n = 28). There were 13 (31.7%) neoplasms and 23 (56.1%) adenomatous polyps; other lesions included inflammatory polyps, diffuse nodular lymphoid hyperplasia, and granulation tissue-all were suspicious for malignancy. Neoplasms included 11 adenocarcinomas and 2 GISTs. Adenomatous polyps included 11 tubular adenomas and 11 tubulovillous adenomas. Twenty-nine out of 34 patients (85.3%) with either adenomatous polyps or adenocarcinoma were successfully removed with the RS alone. Of these, 23 (79.3%) demonstrated clean margins on pathology. Post-endoscopic complications included rectal pain and bleeding.
CONCLUSION(S): This report demonstrates a role of robotic endoscopy for the safe and effective treatment of natural orifice endoscopic surgical resection, with its benefits including traction and triangulation. As endoscopic surgery in the form of ESD evolves, refinement of the tools and techniques of the robotic platform will allow endoscopists to have shorter learning curves and resection of distal colon and rectal polyps and tumors to have higher negative margin rates, potentially allowing more endoscopists the ability to perform ESD
EMBASE:633657215
ISSN: 1572-0241
CID: 4720562
Emerging Antimicrobial Resistant High-Risk clones among Klebsiella pneumoniae: ST307 and ST147
Peirano, Gisele; Chen, Liang; Kreiswirth, Barry N; Pitout, Johann D D
There is an enormous global public health burden due to antimicrobial resistance (AMR) Klebsiella pneumoniae high-risk clones. K. pneumoniae ST307 and ST147 are recent additions to the family of successful clones among these species. Both clones likely emerged in Europe during the early to mid-1990s, and in a relatively short time, became prominent global pathogens, spreading to all continents (with the exception of Antarctica). ST307 and ST147 consist of multiple clades/clusters respectively and are associated with various carbapenemases (i.e. KPCs, NDMs, OXA-48-like and VIMs). ST307 is endemic in Italy, Colombia, USA (Texas), and South Africa, while ST147 is endemic in India, Italy, Greece and certain North African countries. Both clones have been introduced into non-endemic regions leading to world-wide nosocomial outbreaks. Genomic studies showed ST307 and ST147 contain identical gyrA and parC mutations and likely obtained plasmids with blaCTX-M-15 during the early to mid-2000s, which aided in their global distribution. ST307 and ST147 then acquired plasmids with various carbapenemases during the late 2000s, establishing themselves as important AMR pathogens in certain regions. Both clones are likely underreported due to restricted detection methodologies. ST307 and ST147 have the ability to become major threats to public health due to their worldwide distribution, ability to cause serious infections and association with AMR including pan-resistance. The medical community at large, especially those concerned with antimicrobial resistance, should be aware of the looming threat posed by emerging AMR high-risk clones such as K. pneumoniae ST307 and ST147.
PMID: 32747358
ISSN: 1098-6596
CID: 4553772
Diagnostic characteristics of 11 formulae for calculating corrected flow time as measured by a wearable Doppler patch
Kenny, Jon-Émile S; Barjaktarevic, Igor; Mackenzie, David C; Eibl, Andrew M; Parrotta, Matthew; Long, Bradley F; Eibl, Joseph K
BACKGROUND:Change of the corrected flow time (Ftc) is a surrogate for tracking stroke volume (SV) in the intensive care unit. Multiple Ftc equations have been proposed; many have not had their diagnostic characteristics for detecting SV change reported. Further, little is known about the inherent Ftc variability induced by the respiratory cycle. MATERIALS AND METHODS/METHODS:Using a wearable Doppler ultrasound patch, we studied the clinical performance of 11 Ftc equations to detect a 10% change in SV measured by non-invasive pulse contour analysis; 26 healthy volunteers performed a standardized cardiac preload modifying maneuver. RESULTS:, respectively. As an exploratory analysis, we studied 3335 carotid beats for the dispersion of Ftc during quiet breathing using the equations of Wodey and Bazett. The coefficient of variation of Ftc during quiet breathing for these formulae were 0.06 and 0.07, respectively. CONCLUSIONS:Most of the 11 different equations used to calculate carotid artery Ftc from a wearable Doppler ultrasound patch had similar thresholds and abilities to detect SV change in healthy volunteers. Variation in Ftc induced by the respiratory cycle is important; measuring a clinically significant change in Ftc with statistical confidence requires a large sample of beats.
PMCID:7498524
PMID: 32940808
ISSN: 2197-425x
CID: 4626212
D-dimer cut-off points and risk of venous thromboembolism in adult hospitalized patients with COVID-19 [Letter]
Choi, Justin J; Wehmeyer, Graham T; Li, Han A; Alshak, Mark N; Nahid, Musarrat; Rajan, Mangala; Liu, Bethina; Schatoff, Emma M; Elahjji, Rahmi; Abdelghany, Youmna; D'Angelo, Debra; Crossman, Daniel; Evans, Arthur T; Steel, Peter; Pinheiro, Laura C; Goyal, Parag; Safford, Monika M; Mints, Gregory; DeSancho, Maria T
PMID: 32977130
ISSN: 1879-2472
CID: 4606182
[S.l.] : Core IM, 2020
Stories During Challenging Times
Kelleher, Solon; Uloko, Maria; Kalet, Adina; Arora, Vinny; Rafei, El; Hwang, John; Trivedi, Shreya P; Desai, Brinda
(Website)CID: 5325852
Intermittent Recovery of Severe Acute Aortic Regurgitation Arising From Infective Endocarditis [Case Report]
Cordeiro, Christopher; Trehan, Siddhant; Heaton, Joseph N; Bezwada, Prema; Garyali, Samir
This case reports a 47-year-old male with a history of IV drug abuse, presenting with one week of left lower back pain. During the initial treatment, the patient became hemodynamically unstable, requiring vasopressor support. Transthoracic echocardiography (TTE) revealed a 1 cm x 1 cm aortic valve vegetation with severe aortic regurgitation and potential perforation of the valve leaflet. After hemodynamic stability was achieved, the patient left against medical advice, refusing urgent valvular surgery. Subsequent follow-up unveiled repeated recurrence of symptoms and surgical repair of the aortic valve.
PMCID:7566985
PMID: 33083165
ISSN: 2168-8184
CID: 4959602
Asthma-COPD overlap in World Trade Center Health Registry enrollees, 2015-2016
Haghighi, Asieh; Cone, James E; Li, J; de la Hoz, Rafael E
INTRODUCTION/BACKGROUND:Asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO) is a newly redefined form of chronic airway disease and has not been well studied among 9/11-exposed populations with increased prevalence of asthma. We assessed the prevalence and risk factors associated with ACO in an exposure cohort of World Trade Center Health Registry (WTCHR) enrollees. METHODS:This is a longitudinal study, including enrollees with complete data on 9/11/01 exposure at enrollment (2003-2004, Wave 1), asthma and COPD diagnoses and at least 25 years of age at the time of the 2015-2016 (Wave 4) WTCHR survey. Probable ACO was defined as self-reported post-9/11 physician-diagnosed asthma and either emphysema, chronic bronchitis, or COPD. We evaluated whether probable ACO was associated with World Trade Center (WTC)-related exposures, using multivariable logistic regression. RESULTS:Of 36,864 Wave 4 participants, 29,911 were eligible for this analysis, and 1,495 (5.0%) had self-reported post-9/11 probable ACO. After adjusting for demographics and smoking status, we found 38% increased odds of having ACO in enrollees with exposure to the dust cloud, and up to 3.39 times the odds in those with ≥3 injuries sustained on 9/11. Among rescue/recovery workers, ever working on the pile, on the pile on 9/11 or 9/12/01, or working on the WTC site for >7 days showed increased odds ratios of having ACO. CONCLUSION/CONCLUSIONS:Probable ACO is associated with WTC exposures. Further study of ACO is needed to understand the development of this and other environmentally or occupationally-related airway diseases, and how to prevent these in disasters like 9/11.
PMID: 32930623
ISSN: 1532-4303
CID: 4592842
A Telemedicine Approach to Covid-19 Assessment and Triage
Reiss, Allison B; De Leon, Joshua; Dapkins, Isaac P; Shahin, George; Peltier, Morgan R; Goldberg, Eric R
Covid-19 is a new highly contagious RNA viral disease that has caused a global pandemic. Human-to-human transmission occurs primarily through oral and nasal droplets and possibly through the airborne route. The disease may be asymptomatic or the course may be mild with upper respiratory symptoms, moderate with non-life-threatening pneumonia, or severe with pneumonia and acute respiratory distress syndrome. The severe form is associated with significant morbidity and mortality. While patients who are unstable and in acute distress need immediate in-person attention, many patients can be evaluated at home by telemedicine or videoconferencing. The more benign manifestations of Covid-19 may be managed from home to maintain quarantine, thus avoiding spread to other patients and health care workers. This document provides an overview of the clinical presentation of Covid-19, emphasizing telemedicine strategies for assessment and triage of patients. Advantages of the virtual visit during this time of social distancing are highlighted.
PMID: 32927589
ISSN: 1648-9144
CID: 4592702
Associations between obstructive sleep apnea and prescribed opioids among veterans
Chen, Kevin; Yaggi, Henry K; Fiellin, David A; DeRycke, Eric C; Athar, Wardah; Haskell, Sally; Bastian, Lori A
Sleep disruption caused by obstructive sleep apnea (OSA) may be associated with hyperalgesia and may contribute to poor pain control and use of prescription opioids. However, the relationship between OSA and opioid prescription is not well described. We examine this association using cross-sectional data from a national cohort of veterans from recent wars enrolled from October 1, 2001 to October 7, 2014. The primary outcome was the relative risk ratio (RRR) of receiving opioid prescriptions for acute (<90 days/year) and chronic (≥90 days/year) durations compared with no opioid prescriptions. The primary exposure was a diagnosis of OSA. We used multinomial logistic regression to control for factors that may affect diagnosis of OSA or receipt of opioid prescriptions. Of the 1,149,874 patients (mean age 38.0 ± 9.6 years) assessed, 88.1% had no opioid prescriptions, 9.4% had acute prescriptions, and 2.5% had chronic prescriptions. Ten percent had a diagnosis of OSA. Patients with OSA were more likely to be older, male, nonwhite, obese, current or former smokers, have higher pain intensity, and have medical and psychiatric comorbidities. Controlling for these differences, patients with OSA were more likely to receive acute (RRR 2.02 [95% confidence interval 1.98-2.06]) or chronic (RRR 2.15 [2.09-2.22]) opioids. Further dividing opioid categories by high vs low dosage did not yield substantially different results. Obstructive sleep apnea is associated with a two-fold likelihood of being prescribed opioids for pain. Clinicians should consider incorporating OSA treatment into multimodal pain management strategies; OSA as a target for pain management should be further studied.
PMCID:7606219
PMID: 32358418
ISSN: 1872-6623
CID: 4653432